BioMarin Pharmaceutical (BMRN) stock

Last close 57.13 USD (Nov 10, 2026), on the day −0.1 %.

• Sector: Healthcare, Biotechnology.
• Market cap: 11.1B USD.
• Over 52 weeks: low 49.67 USD, high 70.24 USD, price change +8.5 %.
• Analysts' average 12-month target from Yahoo Finance: 91 USD (27 analysts). Not our estimate.

Earnings

• Feb 22, 2027: EPS not yet, estimate 0.89
• Nov 2, 2026: EPS 0.23, estimate −0.11
• Oct 26, 2026: EPS not yet, estimate −0.12
• Aug 6, 2026: EPS 1.20, estimate 0.95
• May 4, 2026: EPS 0.76, estimate 0.91
• Feb 23, 2026: EPS 0.46, estimate 0.56

Which large investors hold it

• Andreas Halvorsen – 1.2 % of the portfolio
• Dodge & Cox – 0.4 % of the portfolio
• Ray Dalio – 0.1 % of the portfolio

In baskets

• Biotech

Similar companies: ARGX · BNTX · EXEL · INCY · MRNA · REGN · VRTX